In vitro activity of ceftazidime-avibactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosa collected in Asia-Pacific countries: results from …

JA Karlowsky, KM Kazmierczak… - Antimicrobial agents …, 2018 - Am Soc Microbiol
β-Lactam resistance rates have been observed to be lower in … of β-lactamases specifically
from the Asia-Pacific region or … bacilli isolated from patients in many Asia-Pacific countries (8…

[HTML][HTML] Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a …

YJ Hu, A Ogyu, BJ Cowling, K Fukuda… - Bulletin of the World …, 2019 - ncbi.nlm.nih.gov
β-lactamase-producing Enterobacteriaceae in children and young adults in the South-…
Asia and the Western Pacific. We also mapped the prevalence of extended-spectrum β-lactamase-…

Past and present perspectives on β-lactamases

K Bush - Antimicrobial agents and chemotherapy, 2018 - Am Soc Microbiol
… bacterium from attack by naturally occurring β-lactams. Their ancestors were presumably …
homology with β-lactamases possessing an active-site serine. Metallo-β-lactamases also exist, …

… susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to …

YH Chen, PR Hsueh, RE Badal, SP Hawser… - Journal of Infection, 2011 - Elsevier
… Susceptibilities to eight antimicrobial agents of extended-spectrum β-lactamase-producing
(ESBL+) and –non-producing (ESBL-) E. coli (A) and K. pneumoniae (B) isolates from …

Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle …

X Bertrand, MJ Dowzicky - Clinical therapeutics, 2012 - Elsevier
… North America reported the lowest rates of extended-spectrum β-lactamase (ESBL)-producing
Klebsiella pneumoniae and Escherichia coli both overall (12.8% and 4.7%, respectively) …

Epidemiology and antimicrobial susceptibility profiles of pathogens causing urinary tract infections in the Asia-Pacific region: Results from the Study for Monitoring …

…, TY Tan, P Kiratisin, Y Ni, B Weinman… - International journal of …, 2016 - Elsevier
… that produce extended-spectrum β-lactamases (ESBLs) are … to include uropathogens
collected from Asia-Pacific countries. The first … Therefore, in this Asia-Pacific multicentre survey, …

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of …

PNA Harris, PA Tambyah, DL Paterson - The Lancet Infectious …, 2015 - thelancet.com
… agents whereby a β-lactam is formulated with a β-lactamase inhibitor to extend the … the
β-lactam antibiotic despite the effect of hydrolysing β-lactamase enzymes, although β-lactamase

… susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the AsiaPacific region: 2008 results …

PR Hsueh, RE Badal, SP Hawser, DJ Hoban… - International journal of …, 2010 - Elsevier
… ) from 32 centres in 11 countries in the AsiaPacific region and tested their in vitro susceptibility
to … High rates of extended-spectrum β-lactamase (ESBL)-producing E. coli and Klebsiella …

Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the …

PL Lu, YC Liu, HS Toh, YL Lee, YM Liu, CM Ho… - International journal of …, 2012 - Elsevier
… pathogens in the Asia Pacific area was … Asia-Pacific region [2, 3]. In 2009, SMART was
expanded to include surveillance of Gram-negative pathogens causing UTIs in the Asia-Pacific

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro …

RR Reinert, DE Low, F Rossi, X Zhang… - Journal of …, 2007 - academic.oup.com
… The activity of tigecycline is also unaffected by other mechanisms such as β-lactamase
production, penicillin-binding protein alterations, macrolide efflux pumps and DNA gyrase …